SOAT1 and histiocytic sarcoma: Targeting the JAK pathway in HS was investigated because the JAK/STAT signal transduction pathways are responsible for the production of numerous pro-inflammatory mediators thought to contribute to the pathology of HS [14,15,16,17,18].